LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.50 | 770.25 | 1310 | 3712 | 0.3529 | 0.2637 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 770.25 | 1273 | 4086 | 0.3115 | 0.2321 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.73 | 770.25 | 1270 | 4086 | 0.3108 | 0.2309 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.95 | 770.25 | 1243 | 4543 | 0.2736 | 0.2055 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.95 | 770.25 | 1307 | 4543 | 0.2876 | 0.2294 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.17 | 770.25 | 1173 | 5010 | 0.2341 | 0.1685 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.17 | 770.25 | 1175 | 5010 | 0.2345 | 0.1692 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.39 | 770.25 | 1167 | 5404 | 0.2159 | 0.1593 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.39 | 770.25 | 1119 | 5404 | 0.2071 | 0.1421 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.61 | 770.25 | 1132 | 5813 | 0.1947 | 0.1412 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.61 | 770.25 | 1170 | 5813 | 0.2013 | 0.1542 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.83 | 770.25 | 1181 | 6223 | 0.1898 | 0.1523 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.83 | 770.25 | 1132 | 6223 | 0.1819 | 0.1363 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.05 | 770.25 | 1142 | 6629 | 0.1723 | 0.1352 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 50.05 | 770.25 | 1118 | 6629 | 0.1686 | 0.1275 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.27 | 770.25 | 1203 | 7058 | 0.1704 | 0.1497 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 52.27 | 770.25 | 1059 | 7058 | 0.1500 | 0.1047 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.49 | 770.25 | 1214 | 7555 | 0.1607 | 0.1481 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 54.49 | 770.25 | 1003 | 7555 | 0.1328 | 0.0835 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.71 | 770.25 | 1163 | 8001 | 0.1454 | 0.1298 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 56.71 | 770.25 | 948 | 8001 | 0.1185 | 0.0634 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.94 | 770.25 | 1248 | 8444 | 0.1478 | 0.1499 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 58.94 | 770.25 | 939 | 8444 | 0.1112 | 0.0590 | MN20160304_L02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 61.16 | 770.25 | 1145 | 8892 | 0.1288 | 0.1189 | MN20160304_L02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 61.16 | 770.25 | 873 | 8892 | 0.0982 | 0.0361 | MN20160304_L02 | K04 |